Galderma Group AG
GALDDrug Manufacturers - Specialty & Generic
CHF 192.85+1.66%As of Oct 30vs prior close
- Market cap
- $54.6B
- P/E (TTM)
- 63.3×
- P/E (FY1)
- 60.5×
- From 52W high
- 0.00%
- EPS (TTM)
- –
- Revenue (LTM)
- $5.9B
- Net margin
- 14.57%
- Dividend yield
- 0.18%
Nomior Score
61
Steady ProfileTop 24% of the scored universe
Growth75
Quality59
Value31
Momentum62
Resilience58
Growth
+11.08%revenue a year over 3 fiscal years
YE22 $3.8BLTM $5.9B
Connections
Revenue to profitYE25
12% of revenue became net profit, up 6 pts on a year.